CD36 as a target for metabolic modulation therapy in cardiac disease

Jan F. C. Glatz*, Fang Wang, Miranda Nabben, Joost J. F. P. Luiken

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)393-400
Number of pages8
JournalExpert Opinion on Therapeutic Targets
Volume25
Issue number5
DOIs
Publication statusPublished - 4 May 2021

Keywords

  • Cardiometabolic disease
  • diabetic cardiomyopathy
  • Cd36
  • lipid metabolism
  • subcellular trafficking
  • CD36
  • cardiac disease
  • metabolic modulation therapy
  • FATTY-ACID TRANSLOCASE
  • SUBSTRATE METABOLISM
  • LIPID-ACCUMULATION
  • GENE-EXPRESSION
  • MEMBRANE
  • PROTEIN
  • HEART
  • INHIBITION
  • RECEPTOR
  • BINDING

Cite this